Pfizer Inc. (PFE.NE)
CAD 11.99
(-2.36%)
CAD 11.99
(-2.36%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 58.49 Billion | 130.61 Billion | 101.91 Billion | 55.86 Billion | 54.63 Billion | 69.53 Billion |
| Cost of Revenue | 24.95 Billion | 49.78 Billion | 43.14 Billion | 15.78 Billion | 16.74 Billion | 20.74 Billion |
| Gross Profit | 33.54 Billion | 80.83 Billion | 58.76 Billion | 40.07 Billion | 37.88 Billion | 48.78 Billion |
| Operating Expenses | 33.54 Billion | 31.94 Billion | 32.69 Billion | 27.89 Billion | 27.91 Billion | 28.96 Billion |
| Selling, General and Administrative Expenses | 14.77 Billion | 17.07 Billion | 15.36 Billion | 15.29 Billion | 16.81 Billion | 18.64 Billion |
| Research and Development Expenses | 10.67 Billion | 14.87 Billion | 17.33 Billion | 12.6 Billion | 11.09 Billion | 10.32 Billion |
| Other Expenses | 8.09 Billion | 2.07 Billion | 4.09 Billion | 950 Million | - | - |
| Cost and Expenses | 58.49 Billion | 81.73 Billion | 75.84 Billion | 43.68 Billion | 44.66 Billion | 49.71 Billion |
| Operating Income | 3.35 Billion | 48.88 Billion | 26.06 Billion | 12.18 Billion | 9.96 Billion | 19.81 Billion |
| Interest Expense | 2.2 Billion | 1.23 Billion | 1.29 Billion | 1.44 Billion | 2.2 Billion | 1.8 Billion |
| Income Tax Expense | -1.11 Billion | 4.33 Billion | 2.32 Billion | 496.28 Million | 820.02 Million | 915.08 Million |
| Earnings before Tax | 1.05 Billion | 45.21 Billion | 30.47 Billion | 9.43 Billion | 15.23 Billion | 15.4 Billion |
| Net Income | 2.11 Billion | 31.37 Billion | 21.97 Billion | 12.28 Billion | 21.59 Billion | 14.45 Billion |
| Earnings Per Share Basic | 0.38 | 7.28 | 4.96 | 2.21 | 3.88 | 2.46 |
| Earnings Per Share Diluted | 0.37 | 7.12 | 4.86 | 2.18 | 3.80 | 2.42 |
| Weighted Average Shares Outstanding | 5.64 Billion | 5.6 Billion | 5.6 Billion | 5.55 Billion | 5.56 Billion | 5.87 Billion |
| Weighted Average Shares Outstanding (Diluted) | 5.7 Billion | 5.73 Billion | 5.7 Billion | 5.63 Billion | 5.67 Billion | 5.97 Billion |
| Gross Margin | 0.57 | 0.62 | 0.58 | 0.72 | 0.69 | 0.70 |
| EBIT Margin | 0.16 | 0.42 | 0.32 | 0.33 | 0.32 | 0.40 |
| Profit Margin | 0.04 | 0.24 | 0.22 | 0.22 | 0.40 | 0.21 |
| EBITDA | 9.55 Billion | 41.03 Billion | 30.79 Billion | 13.26 Billion | 18.64 Billion | 28.09 Billion |
| Earnings Before Tax Margin | 0.06 | 0.37 | 0.26 | 0.22 | 0.18 | 0.28 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 13.28 Billion | 20.06 Billion | 19.4 Billion | 78.95 Billion | 17.74 Billion | 17.1 Billion |
| Cost of Revenue | 3.3 Billion | 5.9 Billion | 11.7 Billion | 39.42 Billion | 14.22 Billion | 6.17 Billion |
| Gross Profit | 9.98 Billion | 14.15 Billion | 7.7 Billion | 39.52 Billion | 3.52 Billion | 10.93 Billion |
| Operating Expenses | 7.72 Billion | 8 Billion | 9.87 Billion | 33.8 Billion | 7.9 Billion | 8.14 Billion |
| Selling, General and Administrative Expenses | 3.71 Billion | 4.66 Billion | 6.09 Billion | - | 4.3 Billion | 4.6 Billion |
| Research and Development Expenses | 2.69 Billion | 3.34 Billion | 3.77 Billion | - | 3.59 Billion | 3.53 Billion |
| Other Expenses | 230 Million | 361 Million | 1.03 Billion | 2.67 Billion | 574 Million | 108 Million |
| Cost and Expenses | 11.02 Billion | 13.91 Billion | 21.57 Billion | 73.23 Billion | 22.12 Billion | 14.31 Billion |
| Operating Income | 2.57 Billion | 6.14 Billion | -2.16 Billion | 5.71 Billion | -4.37 Billion | 2.79 Billion |
| Interest Expense | 778 Million | 790 Million | 688 Million | 2.2 Billion | 695 Million | 508 Million |
| Income Tax Expense | -134 Million | 395.13 Million | -1.08 Billion | -1.5 Billion | -1.29 Billion | -95.35 Million |
| Earnings before Tax | -103 Million | 4.61 Billion | -5.62 Billion | 1.42 Billion | -4.49 Billion | 3.04 Billion |
| Net Income | 41 Million | 4.2 Billion | -4.55 Billion | 2.87 Billion | -3.21 Billion | 3.12 Billion |
| Earnings Per Share Basic | 0.01 | 0.74 | -0.81 | - | -0.57 | 0.55 |
| Earnings Per Share Diluted | 0.01 | 0.74 | -0.81 | - | -0.57 | 0.55 |
| Weighted Average Shares Outstanding | 5.66 Billion | 5.65 Billion | 5.64 Billion | 5.64 Billion | 5.64 Billion | 5.64 Billion |
| Weighted Average Shares Outstanding (Diluted) | 5.69 Billion | 5.69 Billion | 5.64 Billion | 5.7 Billion | 5.64 Billion | 5.71 Billion |
| Gross Margin | 0.75 | 0.71 | 0.40 | 0.50 | 0.20 | 0.64 |
| EBIT Margin | 0.33 | 0.42 | 0.01 | - | -0.13 | 0.29 |
| Profit Margin | 0.00 | 0.21 | -0.23 | 0.04 | -0.18 | 0.18 |
| EBITDA | 4.39 Billion | 8.48 Billion | 104.87 Million | - | -2.28 Billion | 4.9 Billion |
| Earnings Before Tax Margin | 0.19 | 0.31 | -0.11 | 0.07 | -0.25 | 0.16 |
2499
COF-PK
002886
GBT
VKE
BALI